rct
    2021
    High Quality

    Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III Randomized Trial (TASTE)

    Xu J, et al

    Published in Stroke

    Key Findings

    Edaravone dexborneol given within 48 hours improved 90-day functional outcomes compared with edaravone alone, especially in women.

    Conclusions

    Combined free-radical scavenging plus anti-inflammatory therapy improves post-stroke recovery.

    Limitations

    Active comparator, not placebo; single-country trial.

    Outcomes Measured

    Cerebral Infarction Volume
    Primary

    90-day good functional outcomes favored the edaravone dexborneol group, especially in female patients.

    Related Health Concerns

    Ischemic Stroke

    Study Details

    Year:2021
    Sample Size:1,200
    Duration:13 weeks
    Quality Score:8/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.